Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
41 /100
MEDIUM RISK
Score updated Oct 13, 2026

AARD — Aardvark Therapeutics, Inc. Dilution Risk Tracker

Track AARD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AARD — Get alerts when the score changes →

As of October 13, 2026, Aardvark Therapeutics, Inc. (AARD) has a DilutionWatch DilutionScore of 41/100, rated MEDIUM dilution risk. Aardvark Therapeutics, Inc. has a market capitalization of $97.39M, 21.88M shares outstanding, 80 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
30
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AARD.
🔔 Track AARD — Get forecast alerts →

Market Data

Market Cap$97.39M
Shares Outstanding21.88M
Float10.91M
Cash$73.87M
Debt$336.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore41/100DilutionWatch score record
Shares Outstanding21.88MVerified float table or market cache
Public Float10.91MVerified float table or market cache
Market Cap$97.39MMarket data cache
Cash Runway12.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 8.5% shares (2026Q1 vs prior)
80 institutional holders · 11.14M shares
#1 Decheng Capital LLC 3.92M shares
#2 CITADEL ADVISORS LLC 1.30M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.11M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest474.1K
Days to Cover5.3
% of Float4.3%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AARD Dilution Snapshot

Aardvark Therapeutics, Inc. (AARD) has a DilutionScore of 41/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AARD's DilutionScore is currently 41/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 36/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202641/100MEDIUM53 days
Jul 16 – Aug 21, 202636/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

AARD shares outstanding have increased 0.0% from 21.82M (Mar 2026) to 21.82M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202621.82M10.91M▲ 0.43%
Apr 07, 202621.82M10.86M▼ 3.15%
Mar 27, 202621.82M11.22M▲ 0.19%
Mar 25, 202621.82M11.20M▲ 0.20%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track AARD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment AARD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking AARD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AARD
AARD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.